Joel Lewis
2020
In 2020, Joel Lewis earned a total compensation of $753.6K as Chief Executive Officer & President at Galectin Therapeutics.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Option Awards | $486,125 |
| Salary | $164,773 |
| Other | $27,660 |
| Total | $753,558 |
Lewis received $486.1K in option awards, accounting for 65% of the total pay in 2020.
Lewis also received $75K in bonus, $164.8K in salary and $27.7K in other compensation.
Rankings
In 2020, Joel Lewis' compensation ranked 9,718th out of 13,090 executives tracked by ExecPay. In other words, Lewis earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,718 out of 13,090 | 26th |
Division Manufacturing | 4,181 out of 5,621 | 26th |
Major group Chemicals And Allied Products | 1,715 out of 2,254 | 24th |
Industry group Drugs | 1,504 out of 1,954 | 23rd |
Industry Pharmaceutical Preparations | 1,108 out of 1,459 | 24th |
Source: SEC filing on October 17, 2022.
Lewis' colleagues
We found two more compensation records of executives who worked with Joel Lewis at Galectin Therapeutics in 2020.